Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review
Authors
- Yanjie Liu (ORCID: https://orcid.org/0009-0003-3852-7916)
- Shize Wang (ORCID: https://orcid.org/0000-0002-9795-0728)
- Guoliang Shi (ORCID: https://orcid.org/0000-0001-5872-0236)
- Maogang Gao (ORCID: https://orcid.org/0009-0009-6028-0888)
- Yaqing Han (ORCID: https://orcid.org/0000-0003-3725-2343)
- Shaonan Xie
- Guangjie Liu (ORCID: https://orcid.org/0000-0002-6566-9210)
- Qingyi Liu (ORCID: https://orcid.org/0000-0002-6797-6783)
- K.S. Han
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Funders
- Health Commission of Hebei Province